US 10562882
Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions
granted A61PA61P1/04A61P25/04
Quick answer
US patent 10562882 (Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions) held by Takeda Pharmaceutical Company Limited expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/04, A61P25/04, A61P25/18, A61P25/28